Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

CDT

Conduit Pharmaceuticals (CDT)

Conduit Pharmaceuticals Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CDT
FechaHoraFuenteTítuloSímboloCompañía
06/03/202508:35GlobeNewswire Inc.Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing PanelNASDAQ:CDTConduit Pharmaceuticals Inc
20/02/202507:00GlobeNewswire Inc.Conduit Progresses Phase II of its AI Initiative with SarborgNASDAQ:CDTConduit Pharmaceuticals Inc
13/02/202507:00GlobeNewswire Inc.Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus ModelNASDAQ:CDTConduit Pharmaceuticals Inc
11/02/202508:00GlobeNewswire Inc.Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured NoteNASDAQ:CDTConduit Pharmaceuticals Inc
07/02/202507:00GlobeNewswire Inc.Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug DevelopmentNASDAQ:CDTConduit Pharmaceuticals Inc
28/01/202504:30GlobeNewswire Inc.Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial IntelligenceNASDAQ:CDTConduit Pharmaceuticals Inc
23/01/202507:00GlobeNewswire Inc.Conduit Pharmaceuticals Inc. Announces Reverse Stock SplitNASDAQ:CDTConduit Pharmaceuticals Inc
22/01/202507:00GlobeNewswire Inc.Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune PipelineNASDAQ:CDTConduit Pharmaceuticals Inc
12/12/202406:30GlobeNewswire Inc.Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and CyberneticsNASDAQ:CDTConduit Pharmaceuticals Inc
21/11/202406:30GlobeNewswire Inc.Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune DisordersNASDAQ:CDTConduit Pharmaceuticals Inc
19/11/202415:30GlobeNewswire Inc.Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of DirectorsNASDAQ:CDTConduit Pharmaceuticals Inc
01/11/202415:45GlobeNewswire Inc.Conduit Pharmaceuticals Announces Debt Restructuring and Additional NotesNASDAQ:CDTConduit Pharmaceuticals Inc
28/08/202407:00GlobeNewswire Inc.Conduit Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:CDTConduit Pharmaceuticals Inc
12/08/202406:00GlobeNewswire Inc.Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune DisordersNASDAQ:CDTConduit Pharmaceuticals Inc
08/08/202405:30GlobeNewswire Inc.Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class TreatmentsNASDAQ:CDTConduit Pharmaceuticals Inc
16/07/202406:30GlobeNewswire Inc.Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune DiseasesNASDAQ:CDTConduit Pharmaceuticals Inc
13/06/202407:00GlobeNewswire Inc.Conduit Pharmaceuticals to Join Russell 3000® IndexNASDAQ:CDTConduit Pharmaceuticals Inc
29/05/202415:21GlobeNewswire Inc.A Presidio Property Trust Major Investment To Be Part of Russell 2000®NASDAQ:CDTConduit Pharmaceuticals Inc
19/03/202406:00GlobeNewswire Inc.Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific OfficerNASDAQ:CDTConduit Pharmaceuticals Inc
11/03/202406:00GlobeNewswire Inc.Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences HubNASDAQ:CDTConduit Pharmaceuticals Inc
31/01/202407:30GlobeNewswire Inc.Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:CDTConduit Pharmaceuticals Inc
02/11/202307:30GlobeNewswire Inc.Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare ConferenceNASDAQ:CDTConduit Pharmaceuticals Inc
11/10/202307:30GlobeNewswire Inc.Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656NASDAQ:CDTConduit Pharmaceuticals Inc
06/10/202307:30GlobeNewswire Inc.Presidio Property Trust Announces Closing of Merger of Its Sponsored SPAC Murphy Canyon Acquisition Corp Now Trading as Conduit Pharmaceuticals (Nasdaq: CDT and CDTTW)NASDAQ:CDTConduit Pharmaceuticals Inc
22/09/202308:01GlobeNewswire Inc.Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business CombinationNASDAQ:CDTConduit Pharmaceuticals Inc
10/11/200311:26PR Newswire (US)Mohawk/CDT Announces the Release of VersaLite(TM) Indoor/Outdoor Plenum Fiber Optic CableNASDAQ:CDT
 Showing the most relevant articles for your search:NASDAQ:CDT

Su Consulta Reciente

Delayed Upgrade Clock